Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Oracle Corporation (ORCL) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance

Oracle CorporationTrade
Royalty Pharma plc Class A Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Oracle Corporation vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Oracle Corporation trades at $141.39 (market cap $411.34B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.88 (market cap $25.27B). The key difference: Oracle Corporation is far larger — about 16.3× Royalty Pharma plc Class A Ordinary Shares's market cap, and Royalty Pharma plc Class A Ordinary Shares pays the higher dividend (1.66%). Which is the better fit depends on your goals — on Pluang, investors hold Oracle Corporation for 72 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.

ORCLRPRX
Market Cap
$411.34B$25.27B
Volume
41,276,8153,671,183
Sector
TechnologyHealth
52-Week High
$313.00$63.96
52-Week Low
$114.99$35.44
Typical Hold Time
72 Days1 Days
Enterprise Value
$535.15B$32.50B
Dividend Yield
1.47%1.66%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Oracle Corporation

Oracle (ORCL) trades at $143.56, down 0.83% amid a bearish technical signal, though recent earnings consistently beat expectations with Q2 2026 EPS of $1.92 versus $1.74 expected. The company shows strong fundamentals with 2025 revenue of $57.40B and net income margin of 26.36%, while analyst consensus remains bullish with a $236.52 price target. News highlights AI cloud growth of 120% in Q1 2026 but also layoffs and market concerns over AI spending cycles.

The outlook is mixed: robust AI-driven revenue growth and high profitability support upside, but technical weakness and macroeconomic risks like Fed policy pose near-term headwinds. Investors face opportunity from AI demand against volatility from high debt and competitive pressures.

Royalty Pharma plc Class A Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ORCL
74% Buy26% Sell
Avg holding period · 72 Days
RPRX

No sentiment data available yet.

Top news

Latest headlines on both assets

About Oracle Corporation

Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.

Read more on ORCL →

About Royalty Pharma plc Class A Ordinary Shares

Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.

Read more on RPRX →